Trending Articles

  1. Symbiosis expands sterile manufacturing capacity with fill/finish line qualification Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded
  2. New CGT centre in Bangkok to boost Southeast Asia’s biotech ecosystem eXmoor Pharma and Siam Bioscience form a strategic partnership to establish leading cell and gene therapy services in Southeast Asia
  3. Genmab to acquire Merus in $8bn deal to expand late-stage pipeline The acquisition adds breakthrough therapy petosemtamab to Genmab’s portfolio, accelerating its shift to a wholly owned model and supporting multiple new drug launches by 2027
  4. Novartis bolsters kidney disease portfolio with Regulus Therapeutics acquisition Through the acquisition, Novartis will gain access Regulus Therapeutics' oligonucleotide, farabursen, which is designed for the treatment of ADPKD
  5. Prange Pharma to acquire MSD Animal Health manufacturing site in Aprilia, Italy Following completion, the site will relaunch as Aprilia Animal Health, focussing on contract manufacturing of animal health products whilst preserving jobs and expanding...

Upcoming event

CPHI Frankfurt 2025

28–30 October 2025 | Exhibition | Frankfurt, Germany See all

You may also like

Finance The funding will help fast-track clinical trials for treatments addressing dry age-related macular degeneration and severe acute hepatitis, supporting the company’s...

SeaBeLife raises €2 million to advance dual-target cell death therapies

Read more
Research & Development The company expands its international research footprint with a new San Diego institute, strengthening collaborations in one of the world’s leading life-science hubs and...

Daiichi Sankyo launches third global research institute in San Diego

Read more
Finance The SEK 2m deal will see the company’s silica-based NLAB Saga evaluated at production scale by a Chinese insulin manufacturer

Nanologica secures first insulin purification order in China

Read more
Manufacturing Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Read more
Finance The acquisition adds breakthrough therapy petosemtamab to Genmab’s portfolio, accelerating its shift to a wholly owned model and supporting multiple new drug launches by 2027

Genmab to acquire Merus in $8bn deal to expand late-stage pipeline

Read more
Finance eXmoor Pharma and Siam Bioscience form a strategic partnership to establish leading cell and gene therapy services in Southeast Asia

New CGT centre in Bangkok to boost Southeast Asia’s biotech ecosystem

Read more
Finance The deal strengthens Pfizer’s position in the fast-growing obesity market, with additional milestone payments of up to $2.3bn tied to key clinical and regulatory achievements

Pfizer to acquire Metsera in $4.9bn deal, expanding obesity drug pipeline with next-generation incretin and amylin therapies

Read more
Finance The UK-based technology company's adaptive platform will plug directly into pharma, biotech and CRO workflows, giving teams instant access to AI-enabled discovery

DaltonTx secures £4m in seed financing to build adaptive, AI-enabled discovery platforms

Read more
Manufacturing Following completion, the site will relaunch as Aprilia Animal Health, focussing on contract manufacturing of animal health products whilst preserving jobs and expanding...

Prange Pharma to acquire MSD Animal Health manufacturing site in Aprilia, Italy

Read more
Finance The XF drug platform, designed to prevent bacterial resistance and combat Gram-positive infections such as MRSA, represents a high-impact addition to EMV’s life sciences...

EMV Capital subsidiary Moirai acquires Destiny Pharma’s XF-73 antibiotic platform

Read more
Finance The initiative supports leading academic GMP facilities in developing scalable, cost-effective platforms for CAR-T and other cell therapies, reinforcing California’s position...

ScaleReady awards nearly $2m in G-Rex grants to advance cell and gene therapy manufacturing in California

Read more
Finance The new platform enables researchers and patients to create "BioAgents" — autonomous AI co-scientists — to bring a faster, blockchain-verified path from lab to market

Bio Protocol raises $6.9m to launch AI-powered decentralised science platform

Read more
Finance The financing will support preparations for a 2026 FDA Investigational New Drug (IND) application, paving the way for clinical development of the co-therapy designed to restore...

AecorBio raises $1.5m at $30m valuation to advance investigational studies of its novel prostate cancer peptide FT-002a

Read more
Research & Development The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France

Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

Read more
Manufacturing The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand...

Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

Read more
Research & Development The Berlin-based subsidiary will use the grant to advance the KlicMic R&D programme, creating targeted microcystin payloads for ADCs that aim to improve cancer therapy efficacy...

Simris Biologics secures €200K funding to develop microcystin-based payloads for antibody-drug conjugates

Read more